In 351 patients with resectable colorectal peritoneal-only metastases, perioperative systemic therapy plus CRS-HIPEC did not significantly improve median overall survival vs surgery alone (44 vs 39 months; HR 0·85, p=0·28); major postoperative morbidity was 36% vs 26%.
RCTn = 358
Rovers et al. Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial